Author:
Eliseev M. S.,Zhelyabina O. V.,Kirillova I. G.,Korsakova Yu. O.,Cheremushkina E. V.
Reference37 articles.
1. Fomin, A.V., Chronic heart failure in the Russian Federation: what we know today and what we should do, Ross. Kardiol. Zh., 2016, no. 8, pp. 7–13. https://doi.org/10.15829/1560-4071-2016-8-7-13
2. Eliseev, M.S., Novikova, A.M., and Zhelyabina, O.V., Assessment of cardiovascular risk in patients with crystal-induced arthritides and rheumatoid arthritis by the ATP III and Reynolds Risk Score, Nauchno-Prakt.
Revmatol., 2020, vol. 58, no. 5, pp. 512–519. https://doi.org/10.47360/1995-4484-2020-512-51
3. Turkiewicz, A., Kiadaliri, A.A., and Englund, M., Cause-specific mortality in osteoarthritis of peripheral joints, Osteoarthritis Cartilage, 2019, vol. 27, no. 6, pp. 848–854. https://doi.org/10.1016/j.joca.2019.02.793
4. Eliseev, M.S., Cheremushkina, E.V., Zhelyabina, O.V., Chikina, M.N., Kapitonova, A.A., Novikova, A.A., Markelova, E.I., and Lila, A.M., Effect of colchicine, methotrexate, and hydroxychloroquine therapy on cardiovascular outcomes in patients with calcium pyrophosphate crystal deposition disease, Sovrem. Revmatol., 2021, vol. 15, no. 6, pp. 76–83. https://doi.org/10.14412/1996-7012-2021-6-76-83
5. Fomin, I.V., Belenkov, Y.N., Mareev, V.Y., et al., The prevalence of chronic heart failure in the European part of the Russian Federation—data of the EPOKHA-HSN, Zh. Serdechn. Nedostat., 2006, vol. 7, no. 3 (37), pp. 112–115.